Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry

Summary

There is little literature about the clinical presentation and timecourse of postoperative venous thromboembolism (VTE) in different surgical procedures. RIETE is an ongoing, prospective registry of consecutive patients with objectively confirmed, symptomatic acuteVTE.In this analysis,we analysed the baseline characteristics, thromboprophylaxis and therapeutic patterns, timecourse, and three-month outcome of all patients with postoperative VTE. As of January 2006, there were 1,602 patients with postoperativeVTE in RIETE: 393 (25%) after major orthopaedic surgery (145 elective hip arthroplasty, 126 knee arthroplasty, 122 hip fracture); 207 (13%) after cancer surgery; 1,002 (63%) after other procedures. The percentage of patients presenting with clinically overt pulmonary embolism (PE) (48%, 48%, and 50% respectively), the average time elapsed from surgery toVTE (22 ± 16, 24 ± 16, and 21 ± 15 days, respectively), and the three- month incidence of fatal PE (1.3%, 1.4%, and 0.8%, respectively), fatal bleeding (0.8%, 1.0%, and 0.2%, respectively), or major bleeding (2.3%, 2.9%, and 2.8%, respectively) were similar in the three groups. However, the percentage of patients who had received thromboprophylaxis (96%, 76% and 52%, respectively), the duration of prophylaxis (17 ± 9.6, 13 ± 8.9, and 12 ± 11 days, respectively) and the mean daily doses of low-molecular-weight heparin (4,252 ± 1,016, 3,260 ± 1,141, and 3,769 ± 1,650 IU, respectively), were significantly lower in those undergoing cancer surgery or other procedures. In conclusion, the clinical presentation, time-course, and three-month outcome ofVTE was similar among the different subgroups of patients,but the use of prophylaxis in patients undergoing cancer surgery or other procedures was suboptimal.

Keywords

Venous thromboembolism - surgery

Notes

^* A full list of RIETE investigators is given in the Appendix.

• References

• 1 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism: the seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 338s-400s.
• 2 Scurr JH. How long after surgery does the risk of thromboembolism persist ?. Acta Chir Scand 1990; 556: 22-24.
• 3 Huber O, Bounameaux H, Borst F. et al. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127: 310-313.
• 4 Dahl OE, Aspelin T, Arnesen H. et al. Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res 1995; 80: 299-306.
• 5 Planes A, Vochelle N, Darmon JY. et al. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: doubleblind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-228.
• 6 White RH, Romano PS, Zhou H. et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158: 1525-1531.
• 7 Phillips CB, Barrett JA, Losina E. et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg 2003; 85-A: 20-26.
• 8 Dahl OE, Gudmundsen TE, Bjornara BT. et al. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital. A 10-year prospective register of 3,954 patients. Acta Orthop Scand 2003; 74: 299-304.
• 9 Howie C, Hughes H, Watts AC. Venous thromboembolism associated with hip and knee replacement over a ten-year period. A population-based study. J Bone Joint Surg (Br) 2005; 87-B: 1675-1680.
• 10 Soo Hoo NF, Zingmond DS, Lieberman JR. et al. Optimal timeframe for reporting short-term complication rates after total knee arthroplasty. J Arthroplasty 2006; 21: 705-711.
• 11 Bjornara BT, Gudmundsen TE, Dahl OE. Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg (Br) 2006; 88-B: 386-391.
• 12 Anand S, Buch K. Post-discharge symptomatic thromboembolic events in hip fracture patients. Ann R Coll Surg Engl 2007; 89: 517-520.
• 13 Arcelus JI, Monreal M, Caprini JA. et al. The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. J Vasc Surg 2003; 38: 916-922.
• 14 Blanco-Molina A, Trujillo-Santos J, Criado J. et al. and the RIETE Investigators. Venous thrombo-embolism during pregnancy or postpartum: Findings from the RIETE Registry. Thromb Haemost 2007; 97: 186-190.
• 15 Falgà C, Capdevila JA, Soler S. et al. for the RIETE Investigators. Clinical outcome of patients with venous thromboembolism and renal insufficiency. Findings from the RIETE Registry.Thromb Haemost 2007; 98: 771-776.
• 16 Agnelli G, Bolis G, Capussotti L. et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery. The @RISTOS project. Ann Surg 2006; 243: 89-95.
• 17 White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003; 90: 367-368.
• 18 Gangireddy C, Rectenwald JR, Upchurch GR. et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 2007; 45: 335-341.